Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.

Saved in:
Bibliographic Details
Title: Targeting the IL34-CSF1R axis improves metastatic renal cell carcinoma therapy outcome via immune-vascular crosstalk regulation.
Authors: Emanuelli A; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Souleyreau W; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Chouleur T; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Boeckx B; Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.; VIB Center for Cancer Biology, 3000 Leuven, Belgium., Pobiedonoscew Y; University of Bordeaux, INSERM, U1312 BRIC, Modeling Transformation and Resistance in Leukemia Laboratory, Bordeaux, France., Cooley L; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Derieppe MA; Animalerie Mutualisée, Service Commun des Animaleries, Université de Bordeaux, 33000 Bordeaux, France., Martineau J; Animalerie Mutualisée, Service Commun des Animaleries, Université de Bordeaux, 33000 Bordeaux, France., Ambrosetti D; Department of Pathology, University Côte d'Azur, CHU Nice, Nice, France., Bernhard JC; Urology Department, Bordeaux University Hospital, Bordeaux, France., Sawai CM; University of Bordeaux, INSERM, U1312 BRIC, Modeling Transformation and Resistance in Leukemia Laboratory, Bordeaux, France., Lambrechts D; Laboratory of Translational Genetics, Department of Human Genetics, VIB-KU Leuven, 3000 Leuven, Belgium.; VIB Center for Cancer Biology, 3000 Leuven, Belgium., Mathivet T; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France., Bikfalvi A; University of Bordeaux, INSERM, U1312 BRIC, Tumor and Vascular Biology Laboratory, Pessac, France.
Source: IScience [iScience] 2025 May 26; Vol. 28 (6), pp. 112752. Date of Electronic Publication: 2025 May 26 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first